| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.277 | 15.585 | 15.269 | 11.719 | 9.889 | 6.282 | 7.522 | 9.468 | 5.287 | 4.220 |
| Total Income - EUR | 14.278 | 15.585 | 15.269 | 11.719 | 9.889 | 6.282 | 7.522 | 9.468 | 5.287 | 4.220 |
| Total Expenses - EUR | 11.125 | 11.722 | 14.569 | 17.515 | 15.567 | 12.664 | 8.419 | 5.632 | 5.104 | 5.230 |
| Gross Profit/Loss - EUR | 3.152 | 3.864 | 700 | -5.796 | -5.679 | -6.382 | -897 | 3.836 | 182 | -1.011 |
| Net Profit/Loss - EUR | 2.723 | 3.551 | -188 | -5.916 | -5.920 | -6.527 | -1.124 | 3.551 | 82 | -1.126 |
| Employees | 4 | 4 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kovasist Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 786 | 499 | 222 | 0 | 602 | 374 |
| Current Assets | 10.128 | 4.750 | 17.594 | 8.741 | 1.792 | 591 | 520 | 124 | 955 | 1.152 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 320 | 0 |
| Receivables | 1.912 | 1.498 | 2.059 | 1.561 | 867 | 206 | 208 | 113 | 135 | 197 |
| Cash | 8.215 | 3.252 | 15.534 | 7.179 | 926 | 385 | 313 | 11 | 500 | 956 |
| Shareholders Funds | 9.097 | 3.605 | 3.356 | -2.621 | -8.490 | -14.856 | -15.651 | -12.149 | -12.030 | -13.369 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.031 | 1.146 | 14.237 | 11.362 | 11.069 | 15.946 | 16.393 | 12.273 | 13.698 | 14.895 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Kovasist Med Srl